Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors

Social Science and Medicine

Volumn 72, Issue 8, 2011, Pages 1383-1392

  Boyer, Sylvie ^a,b,c   Clerc, Isabelle ^a,b,c   Bonono, Cécile Renée ^d   Marcellin, Fabienne ^a,b,c   Bilé, Paule Christiane ^d   Ventelou, Bruno ^a,b,c,e  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^d Burundi   (Cameroon)

^e Centre National de la Recherche Scientifique   (France)

Author keywords

Adherence; Antiretroviral therapy; Cameroon; Health care supply; Health system; Scaling up; Treatment interruption

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; FINANCE; HEALTH CARE; HEALTH POLICY; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; LOW INCOME POPULATION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAMEROON; DRINKING BEHAVIOR; FAMILY ATTITUDE; FEMALE; FOOD INTAKE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HOSPITAL BED CAPACITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NURSING CARE; PATIENT COMPLIANCE; PSYCHOSOCIAL CARE; RISK FACTOR; SOCIAL DISCRIMINATION; TREATMENT INTERRUPTION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CAMEROON; CONTINUITY OF PATIENT CARE; FEMALE; HEALTH BEHAVIOR; HEALTH CARE SURVEYS; HEALTH FACILITY SIZE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; YOUNG ADULT;

CAMEROON;

EID: 79954815103     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2011.02.030     Document Type: Article

References (43)

1. Atkinson M.J., Petrozzino J.J. An evidence-based review of treatment-related determinants of patients' nonadherence to HIV medications. AIDS Patient Care STDS 2009, 23(11):903-914.
2. Boyer S., Eboko F., Camara M., Abé C., Owona Nguini M.E., Koulla-Shiro S., Moatti J.P. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS 2010, 24(Suppl. 1):S5-S16.
3. Boyer S., Marcellin F., Ongolo-Zogo P., Abega S.C., Nantchouang R., Spire B., Moatti J.P. Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bulletin of World Health Organisation 2009, 87(4):279-287.
4. Brinkhof M.W., Dabis F., Myer L., Bangsberg D.R., Boulle A., Nash D., et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of World Health Organisation 2008, 86(7):559-567.
5. Bryk A., Raudenbush S.W. Hierarchical Linear Models: Applications and data analysis methods 2002, Sage Publications, London.
6. Camara M., D'Almeida C., Orsi F., Coriat B. Procurement policies, governance models and ARV availability in French-speaking African countries: an overview. The political economy of HIV/AIDS in developing countries: TRIPS, public health systems and free access 2008, 225-257. Edward Eldar Publishing and ANRS, Northampton. B. Coriat (Ed.).
7. Carrieri P., Cailleton V., Le Moing V., Spire B., Dellamonica P., Bouvet E., et al. The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. Journal of Acquired Immuno Deficiency Syndrome 2001, 28(3):232-239.
8. Chabot J. The Bamako initiative. Lancet 1988, 2(8624):1366-1367.
9. Cheng J., Edwards L.J., Maldonado-Molina M.M., Komro K.A., Muller K.E. Real longitudinal data analysis for real people: building a good enough mixed model. Statistics in Medicine 2010, 29(4):504-520.
10. Cohen R., Lynch S., Bygrave H., Eggers E., Vlahakis N., Hilderbrand K., et al. Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years. Journal of International AIDS Society 2009, 12(1):23.
11. Duggan J.M., Locher A., Fink B., Okonta C., Chakraborty J. Adherence to antiretroviral therapy: a survey of factors associated with medication usage. AIDS Care 2009, 21(9):1141-1147.
12. Ford N., Nachega J.B., Engel M.E., Mills E.J. Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet 2009.
13. Goldstein H., Browne W.J., Rasbach J. Partitioning variation in multilevel models. Understanding Statistics 2002, 1:223-232.
14. Gupta R.K., Hill A., Sawyer A.W., Cozzi-Lepri A., von Wyl V., Yerly S., et al. Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. Lancet Infectious Diseases 2009, 9(7):409-417.
15. Harries A.D., Schouten E.J., Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet 2006, 367(9525):1870-1872.
16. Hox J. Multilevel analysis: Techniques and applications 2002, Lawrence Erlbaum Associates, Mahwah, NJ.
17. Justice A.C., Holmes W., Gifford A.L., Rabeneck L., Zackin R., Sinclair G., et al. Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology 2001, 54(Suppl. 1):S77-90.
18. Koenig S.P., Leandre F., Farmer P.E. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS 2004, 18(Suppl. 3):S21-25.
19. Kouanfack C., Montavon C., Laurent C., Aghokeng A., Kenfack A., Bourgeois A., et al. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Clinical Infectious Diseases 2009, 48(9):1318-1322.
20. Marcellin F., Boyer S., Protopopescu C., Dia A., Ongolo-Zogo P., Koulla-Shiro S., et al. Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaounde, Cameroon (EVAL survey, ANRS 12-116). Tropical Medicine & International Health 2008, 13(12):1470-1478.
21. Mills E.J., Nachega J.B., Bangsberg D.R., Singh S., Rachlis B., Wu P., et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine 2006, 3(11):e438.
22. Mills E.J., Nachega J.B., Buchan I., Orbinski J., Attaran A., Singh S., et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006, 296(6):679-690.
23. National Guidelines for antiretroviral treatment for people living with HIV, district hospital level 2005, Ministry of Public Health, Ministry of Public Health, Republic of Cameroon, Yaoundé, (in French).
24. Mugusi F., Mugusi S., Bakari M., Hejdemann B., Josiah R., Janabi M., et al. Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience. Tropical Medicine & International Health 2009, 14(10):1226-1232.
25. Towards universal access to care and treatment for adults and children living with HIV/AIDS in Cameroon 2006, National AIDS Control Committee, Progress Report n°4, Ministry of Public Health, Republic of Cameroon, Yaoundé, Cameroon, (in French).
26. Towards universal access to care and treatment for adults and children living with HIV/AIDS in Cameroon 2009, National AIDS Control Committee, Progress Report n°16, Ministry of Public Health, Republic of Cameroon, Yaoundé, Cameroon, (in French).
27. Nkoa F.C., Eboko F., Moatti J.P. International Cooperation and financing of the fight againgt HIV/Aids in Africa: the experience of Cameroon. Decentralised access to HIV/AIDS treatment: Evaluation of the Cameroonian experience 2010, 13-27. ANRS, Social Sciences and Aids collection, Paris, France, (in French). F. Eboko, C. Abé, C. Laurent (Eds.).
28. van Oosterhout J.J., Bodasing N., Kumwenda J.J., Nyirenda C., Mallewa J., Cleary P.R., et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Tropical Medicine & International Health 2005, 10(5):464-470.
29. Oyugi J.H., Byakika-Tusiime J., Charlebois E.D., Kityo C., Mugerwa R., Mugyenyi P., Bangsberg D.R. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immuno Deficiency Syndrome 2004, 36(5):1100-1102.
30. Oyugi J.H., Byakika-Tusiime J., Ragland K., Laeyendecker O., Mugerwa R., Kityo C., et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007, 21(8):965-971.
31. Parienti J.J., Das-Douglas M., Massari V., Guzman D., Deeks S.G., Verdon R., Bangsberg D.R. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One 2008, 3(7):e2783.
32. Raudenbush S.W., Bryk A.S., Congdon R. HLM 6 for Windows [Computer software] 2004, I. Scientific Software International, Lincolnwood, IL.
33. Rice N., Jones A. Multilevel models and health economics. Health Economics 1997, 6(6):561-575.
34. Samb B., Celletti F., Holloway J., Van Damme W., De Cock K.M., Dybul M. Rapid expansion of the health workforce in response to the HIV epidemic. New England Journal of Medicine 2007, 357(24):2510-2514.
35. Samb B., Evans T., Dybul M., Atun R., Moatti J.P., Nishtar S., et al. An assessment of interactions between global health initiatives and country health systems. Lancet 2009, 373(9681):2137-2169.
36. Sayles J.N., Wong M.D., Kinsler J.J., Martins D., Cunningham W.E. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. Journal of General Internal Medicine 2009, 24(10):1101-1108.
37. Report on the global AIDS epidemic 2008, UNAIDS, WHO-UNAIDS, Geneva.
38. Van Damme W., Kober K., Kegels G. Scaling-up antiretroviral treatment in Southern African countries with human resource shortage: how will health systems adapt?. Social Science & Medicine 2008, 66(10):2108-2121.
39. Health systems: Improving performance, the World Health Report 2000, WHO, World Health Organization, Geneva.
40. World health Statistics 2009, WHO, World Health Organization, Geneva.
41. Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector 2009, WHO, UNICEFUNICEF, UNAIDSUNAIDS, (Geneva).
42. Wouters E., Van Damme W., van Rensburg D., Meulemans H. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa. AIDS 2008, 22(18):2545-2548.
43. Wouters E., Van Damme W., Van Loon F., van Rensburg D., Meulemans H. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome. Socical Science & Medicine 2009, 69(8):1177-1185.